一个小分子直接准NLRP3,促进炎酶激活和抗瘤免疫
Xuemei Liu1, Hongbin He1, Minghui Qi1
1National Key Laboratory of immune response and immunotherapy, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
Cell death & disease
|April 4, 2025
概括
用2-guanidinobezimidazole (2GBI) 准NLRP3炎症组可以增强抗瘤免疫力. 这种方法克服了免疫检查点阻塞 (ICB) 抵抗,为癌症治疗提供了新的策略.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 免疫检查点阻塞 (ICB) 疗法在癌症治疗中表现有前途,但在有效性方面面临局限性.
- 在瘤微环境中的NLRP3炎症酶激活可以增强抗瘤免疫力,但其在克服ICB抗性的作用尚未完全理解.
研究的目的:
- 调查直接准NLRP3炎症酶是否可以克服ICB抵抗.
- 评估一种针对NLRP3.3的新型小分子化合物的抗瘤作用.
主要方法:
- 一种小分子化合物-2-guanidinobezimidazole (2GBI) 被用来直接准NLRP3.
- 炎症酶激活,免疫细胞透和瘤生长被评估为对2GBI治疗的反应,单独或与ICB结合.
主要成果:
- 2GBI直接与NLRP3结合,诱导炎酶激活,独立于已知的通路.
- 单独2GBI治疗促进了抗瘤免疫力,并以NLRP3依赖的方式抑制了瘤生长.
- 结合2GBI和ICB治疗显示出协同作用的抗瘤作用,并克服了ICB的耐药性.
结论:
- 使用2GBI直接准NLRP3是一种可行的策略,可以诱导抗瘤免疫力.
- 这种方法有可能提高免疫检查点阻塞疗法在癌症治疗中的有效性.
更多相关视频
相关概念视频
The Intrinsic Apoptotic Pathway
5.7K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
5.7K
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Cells of the Innate Immune Response
1.2K
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
1.2K
Tumor Immunotherapy
441
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
441
lncRNA - Long Non-coding RNAs
8.4K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.4K


